Pseudocannabinoid, H4CBD, Enhances Lipid Catabolism to Reduce Visceral Adiposity and Large Adipocyte Size in Advanced Metabolic Syndrome

The Journal of Pharmacology and Experimental Therapeutics · Elsevier

Аннотация

Publication date: Available online 17 November 2026 Source: The Journal of Pharmacology and Experimental Therapeutics Author(s): Jessica N. Wilson, Dora A. Mendez, Marisol Hernandez Garcia, Nikolay Shevchenko, Mark Mascal, Nicholas V. DiPatrizio, Rudy M. Ortiz

Читать у издателя →

Похожие статьи